US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on April 21 for "Globin gene therapy for treating hemoglobinopathies" (American, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,848, issued on April 21, was assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER (New York).

"Globin gene therapy for treating hemoglobinopathies" was invented by Michel Sadelain (New York) and Annalisa Cabriolu (Villacidro, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The presently disclosed subject matter provides for expression cassettes that allow for expression of a globin gene or a functional portion thereof, vectors comprising thereof, and cells transduced with such expression cassettes and vectors. The presently disclosed subject matter further provides methods for treating a hemoglobinopathy in a subject comprising administering an ...